Copyright
©The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Gastroenterol. Apr 21, 2024; 30(15): 2118-2127
Published online Apr 21, 2024. doi: 10.3748/wjg.v30.i15.2118
Published online Apr 21, 2024. doi: 10.3748/wjg.v30.i15.2118
Urgent one-stage endoscopic treatment for choledocholithiasis related moderate to severe acute cholangitis: A propensity score-matched analysis
Yang Zhou, Shuai-Jing Huang, Yan Liang, Xiao Liang, Masoom Wali, Ya-Dong Feng, Department of Gastroenterology, Zhongda Hospital, School of Medicine, Southeast University, Nanjing 210009, Jiangsu Province, China
Yin-Qiu Zhang, Department of Gastroenterology, BenQ Medical Center, The Affiliated BenQ Hospital of Nanjing Medical University, Nanjing 210019, Jiangsu Province, China
Co-first authors: Yang Zhou and Ying-Qiu Zhang.
Author contributions: Zhou Y wrote the manuscript; Feng YD was responsible for the case design; Zhang YQ and Huang SJ collected the data and analyzed the data; Liang Y and Wali M revised the manuscript; and all the authors have read and agreed to the published version of the manuscript.
Institutional review board statement: The study was conducted at Zhongda Hospital Affiliated with Southeast University. The study was approved by the Ethics Committee (2019ZDSYLL094-P01).
Informed consent statement: All study participants, or their legal guardian, provided informed written consent prior to study enrollment.
Conflict-of-interest statement: All the authors report no relevant conflicts of interest for this article.
Data sharing statement: All the data are available upon request to the corresponding author (email: drfengyd@126.com).
STROBE statement: The authors have read the STROBE Statement-checklist of items, and the manuscript was prepared and revised according to the STROBE Statement-checklist of items.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Ya-Dong Feng, MD, PhD, Chief Doctor, Department of Gastro enterology, Zhongda Hospital, School of Medicine, Southeast University, No. 87 Dingjiaqiao Road, Nanjing 210009, Jiangsu Province, China. drfengyd@126.com
Received: January 18, 2024
Peer-review started: January 18, 2024
First decision: February 9, 2024
Revised: February 19, 2024
Accepted: March 27, 2024
Article in press: March 27, 2024
Published online: April 21, 2024
Processing time: 91 Days and 23.8 Hours
Peer-review started: January 18, 2024
First decision: February 9, 2024
Revised: February 19, 2024
Accepted: March 27, 2024
Article in press: March 27, 2024
Published online: April 21, 2024
Processing time: 91 Days and 23.8 Hours
Core Tip
Core Tip: We investigated the safety and feasibility of one-stage endoscopic treatment for moderate to severe acute cholangitis. Our study found that patients who underwent endoscopic retrograde cholangiopancreatography within 24 h had a shorter intensive care unit stay, a shorter duration of antibiotic use, and a shorter hospital stay.